Panel discussion on future of rubella virus vaccines.
D000293:Adolescent; D000328:Adult; D000818:Animals; D002675:Child, Preschool; D000013:Congenital Abnormalities / Q000517:prevention & control; D005193:Family Planning Services; D005260:Female; D005315:Fetal Diseases / Q000517:prevention & control; D000882:Haplorhini; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D008297:Male; D008403:Mass Screening; D008431:Maternal-Fetal Exchange; D009092:Mucous Membrane / Q000276:immunology; D011247:Pregnancy; D011634:Public Health; D011817:Rabbits; D012137:Respiratory System / Q000276:immunology; D012409:Rubella / Q000151:congenital / Q000276:immunology* / Q000517:prevention & control; D012411:Rubella Vaccine / Q000009:adverse effects; D012412:Rubella virus; D013997:Time Factors; D014611:Vaccination; D014765:Viral Vaccines
D012411:Rubella Vaccine; D014765:Viral Vaccines